Is PXMD or GBDC a better dividend investment in 2026?

PXMD currently yields 285714.29% with a 5% 5-year dividend growth rate. GBDC yields 11.86% with 5% growth. The better choice depends on your goal: PXMD offers higher current income.

What is the dividend yield difference between PXMD and GBDC?

PXMD has a forward dividend yield of 285714.29% ($2.00/share annually). GBDC yields 11.86% ($1.50/share annually). The yield gap is 285702.43 percentage points.

Home › Compare › PXMD vs GBDC

PXMD vs GBDC: Dividend Comparison 2026

PXMD yields 285714.29% · GBDC yields 11.86%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PXMD wins by $1.734986541242196e+31M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PXMD

● Live price

285714.29%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.734986541242196e+31M

Annual income

$17,337,928,197,276,910,000,000,000,000,000,000,000.00

Full PXMD calculator →

GBDC

● Live price

11.86%

Share price

$12.65

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.85M

Annual income

$16,450,733.83

Full GBDC calculator →

Portfolio growth — PXMD vs GBDC

📍 PXMD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PXMD	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PXMD + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PXMD pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PXMD

Annual income on $10K today (after 15% tax)

$24,285,714.29/yr

After 10yr DRIP, annual income (after tax)

$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.91/yr

After 10yr DRIP, annual income (after tax)

$13,983,123.76/yr

At 15% tax rate, PXMD beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PXMD + GBDC for your $10,000?

PXMD: 50%GBDC: 50%

100% GBDC50/50100% PXMD

Portfolio after 10yr

$8.67493270621098e+30M

Annual income

$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr

Blended yield

99.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

PXMD

No analyst data

Altman Z

-176.3

Piotroski

2/9

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.7% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PXMD buys

GBDC buys

No recent congressional trades found for PXMD or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPXMDGBDC

Forward yield	285714.29% ✓	11.86%
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.1% ✓
Portfolio after 10y	$1.734986541242196e+31M	$20.85M ✓
Annual income after 10y	$17,337,928,197,276,910,000,000,000,000,000,000,000.00 ✓	$16,450,733.83
Total dividends collected	$1.734908400352195e+31M	$20.43M ✓
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: PXMD vs GBDC ($10,000, DRIP)

Year	PXMD Portfolio	PXMD Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1← crossover	$28,582,129	$28,571,428.57	$12,492	$1,791.70	+$28.57M → PXMD
2	$76,351,353,429	$76,320,770,551.21	$16,527	$3,160.58	+$76351.34M → PXMD
3	$190,619,493,207,524	$190,537,797,259,355.30	$23,588	$5,904.90	+$190619493.18M → PXMD
4	$444,781,927,427,195,200	$444,577,964,569,463,100.00	$37,141	$11,901.65	+$444781927427.16M → PXMD
5	$969,967,353,346,567,200,000	$969,491,436,684,220,000,000.00	$66,205	$26,463.38	+$969967353346567.00M → PXMD
6	$1,976,961,629,315,093,000,000,000	$1,975,923,764,247,012,300,000,000.00	$137,452	$66,612.65	+$1976961629315092992.00M → PXMD
7	$3,765,923,944,594,039,000,000,000,000	$3,763,808,595,650,671,000,000,000,000.00	$342,372	$195,298.53	+$3.765923944594039e+21M → PXMD
8	$6,704,681,437,057,684,000,000,000,000,000	$6,700,651,898,436,968,000,000,000,000,000.00	$1,053,292	$686,954.33	+$6.704681437057683e+24M → PXMD
9	$11,156,275,836,497,016,000,000,000,000,000,000	$11,149,101,827,359,364,000,000,000,000,000,000.00	$4,111,439	$2,984,416.95	+$1.1156275836497015e+28M → PXMD
10	$17,349,865,412,421,960,000,000,000,000,000,000,000	$17,337,928,197,276,910,000,000,000,000,000,000,000.00	$20,849,974	$16,450,733.83	+$1.734986541242196e+31M → PXMD

PXMD vs GBDC: Complete Analysis 2026

PXMD — Stock

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human african trypanosomiasis. It is also involved in developing PAX-102, an intranasal formulation of suramin for neurologic indications. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC.

Full PXMD Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this PXMD vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PXMD vs SCHD PXMD vs JEPI PXMD vs O PXMD vs KO PXMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.